Edward J Miller, MD, PhD

• Adam Schussheim
• Albert Sinusas
• Alexandria Brackett
• Alyssa Ann Grimshaw
• Amarnath Annapureddy
• Attila Feher
• Brenda Cabrera-Mendoza
• Brett King
• Cesia Gallegos Kattan
• Chi Liu
• Christopher Maulion
• Dana Peters
• Daniel Jacoby
• David van Dijk
• E Kevin Hall
• Ehimen Aneni
• Eric Velazquez
• Erica Herzog
• Erin Faherty
• Evangelos Oikonomou
• Forrester Lee
• Gita Pathak
• Hamid Mojibian
• Henry Yaggi
• Ian Ferguson
• Ian Odell
• James V. Freeman
• Jean-Dominique Gallezot
• Jennifer M. Kwan
• Jeptha Curtis
• Jeremy Asnes
• Jeremy Steele
• Jiasheng Zhang
• John Onofrey
• John Stendahl
• Joyce Oen-Hsiao
• Karl Minges
• Kim Germaine Emiel Smolderen
• Lauren A. Baldassarre
• Lavanya Bellumkonda
• Lawrence Young
• Lynda Rosenfeld
• Medhat Ghaly
• Mehran M Sadeghi
• Michael Kapinos
• Mike Ming-Qiang Wenn
• MingDe Lin
• Monique Hinchcliff
• Mridu Gulati
• Nabil Boutagy
• Nihar Desai
• Renato Polimanti
• Ricardo Avendaño
• Richard Flavell
• Robert Elder
• Robert Homer
• Rohan Khera
• Samit Shah
• Stephanie Thorn
• Steven Pfau
• Yi-Hwa Liu
• Yongfei Wang

Amyloid; Amyloidosis; Cardiology; Radiology; Radionuclide Imaging; Sarcoidosis; Positron Emission Tomography Computed Tomography; Single Photon Emission Computed Tomography Computed Tomography

Cardiovascular Diseases; Health Equity, Disparities, Social Determinants and Justice

• Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 casesChan N, Einstein A, Griffin J, Rosenblum H, Teruya S, Cuomo M, De Los Santos J, DeLuca A, Johnson L, Kinkhabwala M, Leb J, Mintz A, Fine D, Helmke S, Muralidhar V, Pandey S, Sabogal N, Saith S, Winburn M, Smiley D, Miller E, Ruberg F, Maurer M. Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases Journal Of Nuclear Cardiology 2023, 1-9. PMID: 37311914, DOI: 10.1007/s12350-023-03310-7.
• 0488 The Relationship between Myocardial Blood Flow and Diastolic Function in a Clinical Population with Obstructive Sleep ApneaAneni E, Saeed G, Thorn S, Miller E, Sinusas A, Yaggi H. 0488 The Relationship between Myocardial Blood Flow and Diastolic Function in a Clinical Population with Obstructive Sleep Apnea Sleep 2023, 46: a217-a217. DOI: 10.1093/sleep/zsad077.0488.
• DuSFE: Dual-Channel Squeeze-Fusion-Excitation co-attention for cross-modality registration of cardiac SPECT and CTChen X, Zhou B, Xie H, Guo X, Zhang J, Duncan J, Miller E, Sinusas A, Onofrey J, Liu C. DuSFE: Dual-Channel Squeeze-Fusion-Excitation co-attention for cross-modality registration of cardiac SPECT and CT Medical Image Analysis 2023, 88: 102840. PMID: 37216735, DOI: 10.1016/j.media.2023.102840.
• Time and event-specific deep learning for personalized risk assessment after cardiac perfusion imagingPieszko K, Shanbhag A, Singh A, Hauser M, Miller R, Liang J, Motwani M, Kwieciński J, Sharir T, Einstein A, Fish M, Ruddy T, Kaufmann P, Sinusas A, Miller E, Bateman T, Dorbala S, Di Carli M, Berman D, Dey D, Slomka P. Time and event-specific deep learning for personalized risk assessment after cardiac perfusion imaging Npj Digital Medicine 2023, 6: 78. PMID: 37127660, PMCID: PMC10151323, DOI: 10.1038/s41746-023-00806-x.
• Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imagingWilliams M, Bednarski B, Pieszko K, Miller R, Kwiecinski J, Shanbhag A, Liang J, Huang C, Sharir T, Dorbala S, Di Carli M, Einstein A, Sinusas A, Miller E, Bateman T, Fish M, Ruddy T, Acampa W, Hauser M, Kaufmann P, Dey D, Berman D, Slomka P. Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging European Journal Of Nuclear Medicine And Molecular Imaging 2023, 1-13. PMID: 37067586, DOI: 10.1007/s00259-023-06218-z.
• Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) StudyRuberg F, Blaner W, Chiuzan C, Connors L, Einstein A, Fine D, Helmke S, Kurian D, Pandey S, Raiszadeh F, Rodriguez C, Sabogal N, Teruya S, Winburn M, Chung W, Cohn E, Miller E, Kelly J, Maurer M. Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study Journal Of The American Heart Association 2023, 12: e028534. PMID: 37066788, PMCID: PMC10227254, DOI: 10.1161/jaha.122.028534.
• The Association Between Body Mass Index And Functional Status In Minority Patients With Heart Failure With Preserved Ejection Fraction: The SCAN-MP StudyDriggin E, Rosenblum H, Teruya S, Rodriguez C, Kurian D, Raiszadeh F, Fine D, Sabogal N, Edmiston J, Massillon D, Winburn M, Miller E, Ruberg F, Maurer M. The Association Between Body Mass Index And Functional Status In Minority Patients With Heart Failure With Preserved Ejection Fraction: The SCAN-MP Study Journal Of Cardiac Failure 2023, 29: 668-669. DOI: 10.1016/j.cardfail.2022.10.299.
• Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosisFeher A, Miller E, Peters D, Mojibian H, Sinusas A, Hinchcliff M, Baldassarre L. Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis Rheumatology International 2023, 43: 849-858. PMID: 36894756, DOI: 10.1007/s00296-023-05294-6.
• RB-82 PET DERIVED REGIONAL MYOCARDIAL BLOOD FLOW IS ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS PRESENTING WITH ACUTE CHEST PAINTrejo-Paredes C, Hu J, Shah S, Liu Y, Smolderen K, Hurtado C, Sinusas A, Miller E. RB-82 PET DERIVED REGIONAL MYOCARDIAL BLOOD FLOW IS ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN Journal Of The American College Of Cardiology 2023, 81: 1502. DOI: 10.1016/s0735-1097(23)01946-0.
• CORONARY ARTERY CALCIFICATIONS ARE A BETTER PREDICTOR OF CARDIOVASCULAR OUTCOMES THAN ISCHEMIC ECG CHANGES IN PATIENTS WITH NORMAL PERFUSION ON EXERCISE SPECTShi T, Kokkinidis D, Agarwal R, Liu Y, Sinusas A, Miller E, Feher A. CORONARY ARTERY CALCIFICATIONS ARE A BETTER PREDICTOR OF CARDIOVASCULAR OUTCOMES THAN ISCHEMIC ECG CHANGES IN PATIENTS WITH NORMAL PERFUSION ON EXERCISE SPECT Journal Of The American College Of Cardiology 2023, 81: 1498. DOI: 10.1016/s0735-1097(23)01942-3.
• IN PATIENTS UNDERGOING NUCLEAR MYOCARDIAL PERFUSION IMAGING, RHEUMATOID ARTHRITIS IS ASSOCIATED WITH INCREASED RISK OF ADVERSE CARDIOVASCULAR EVENTS INDEPENDENT OF MYOCARDIAL ISCHEMIAPires J, Oikonomou E, Agarwal R, Liu Y, miller E, Sinusas A, Feher A. IN PATIENTS UNDERGOING NUCLEAR MYOCARDIAL PERFUSION IMAGING, RHEUMATOID ARTHRITIS IS ASSOCIATED WITH INCREASED RISK OF ADVERSE CARDIOVASCULAR EVENTS INDEPENDENT OF MYOCARDIAL ISCHEMIA Journal Of The American College Of Cardiology 2023, 81: 1467. DOI: 10.1016/s0735-1097(23)01911-3.
• ASSOCIATION OF RB-82 PET DERIVED REGIONAL MYOCARDIAL BLOOD FLOW TO SEVERITY OF ANGIOGRAPHIC CORONARY ARTERY STENOSIS IN PATIENTS PRESENTING WITH ACUTE CHEST PAINHu J, Trejo-Paredes C, Shah S, Liu Y, Smolderen K, Hurtado C, Sinusas A, Miller E, Kattan C. ASSOCIATION OF RB-82 PET DERIVED REGIONAL MYOCARDIAL BLOOD FLOW TO SEVERITY OF ANGIOGRAPHIC CORONARY ARTERY STENOSIS IN PATIENTS PRESENTING WITH ACUTE CHEST PAIN Journal Of The American College Of Cardiology 2023, 81: 1409. DOI: 10.1016/s0735-1097(23)01853-3.
• MECHANISTIC EVALUATION OF AN AI-DRIVEN CLINICAL DECISION SUPPORT TOOL TO PERSONALIZE THE USE OF ANATOMICAL TESTING IN SUSPECTED CORONARY ARTERY DISEASEOikonomou E, Suchard M, Miller E, Velazquez E, Khera R. MECHANISTIC EVALUATION OF AN AI-DRIVEN CLINICAL DECISION SUPPORT TOOL TO PERSONALIZE THE USE OF ANATOMICAL TESTING IN SUSPECTED CORONARY ARTERY DISEASE Journal Of The American College Of Cardiology 2023, 81: 1360. DOI: 10.1016/s0735-1097(23)01804-1.
• DEEP LEARNING ACCURATELY QUANTIFIES PER VESSEL CORONARY CALCIUM SCORES IN A LARGE MULTICENTER INTERNATIONAL REGISTRYShanbhag A, Zhou J, miller R, Pieszko K, Lemley M, Killekar A, Van Kriekinge S, Gransar H, Kavanagh P, miller E, Bateman T, Dey D, Berman D, Slomka P. DEEP LEARNING ACCURATELY QUANTIFIES PER VESSEL CORONARY CALCIUM SCORES IN A LARGE MULTICENTER INTERNATIONAL REGISTRY Journal Of The American College Of Cardiology 2023, 81: 1370. DOI: 10.1016/s0735-1097(23)01814-4.
• Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP studyPandey S, Teruya S, Rodriguez C, Deluca A, Kinkhabwala M, Johnson L, Fine D, Sabogal N, Winburn M, Castillo M, Bhatia K, Malkovskaya R, Raiszadeh F, Kurian D, Miller E, Einstein A, Maurer M, Ruberg F. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study Journal Of Nuclear Cardiology 2023, 1-6. PMID: 36823486, DOI: 10.1007/s12350-023-03203-9.
• Correction to: Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imagingFeher A, Pieszko K, Miller R, Lemley M, Shanbhag A, Huang C, Miras L, Liu Y, Sinusas A, Miller E, Slomka P. Correction to: Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging Journal Of Nuclear Cardiology 2023, 30: 860-863. PMID: 36598750, DOI: 10.1007/s12350-022-03196-x.
• Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG RadiotracersShi T, Miller E. Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers Current Cardiovascular Imaging Reports 2023, 16: 1-9. PMID: 36926261, PMCID: PMC9996562, DOI: 10.1007/s12410-023-09574-4.
• Obstructive Sleep Apnea Severity is Associated with Abnormal Myocardial 82Rubidium PET Blood Flow ReserveAneni E, Chen J, Thorn S, Miller E, Sinusas A, Yaggi H. Obstructive Sleep Apnea Severity is Associated with Abnormal Myocardial 82Rubidium PET Blood Flow Reserve Sleep Medicine 2022, 100: s261. DOI: 10.1016/j.sleep.2022.05.703.
• Abstract 14839: Clinical, Polysomnographic and Echocardiographic Correlates of Excessive Daytime SleepinessSaeed G, Aneni E, Otite F, Thorn S, Miller E, Sinusas A, Yaggi H. Abstract 14839: Clinical, Polysomnographic and Echocardiographic Correlates of Excessive Daytime Sleepiness Circulation 2022, 146: a14839-a14839. DOI: 10.1161/circ.146.suppl_1.14839.
• Abstract 13798: Obstructive Sleep Apnea Severity and Abnormal Right Ventricular Flow Reserve in Adult OSA Patients Who Received Rubidium-82 Cardiac PET Perfusion ImagingAneni E, Miller E, Saeed G, deKemp R, KLEIN R, Beanlands R, Yaggi H, Sinusas A, Thorn S. Abstract 13798: Obstructive Sleep Apnea Severity and Abnormal Right Ventricular Flow Reserve in Adult OSA Patients Who Received Rubidium-82 Cardiac PET Perfusion Imaging Circulation 2022, 146: a13798-a13798. DOI: 10.1161/circ.146.suppl_1.13798.
• Abstract 9447: The Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations StudyMadhani A, Sabogal N, Massillon D, Paul L, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein A, Miller E, Connors L, Maurer M, Ruberg F. Abstract 9447: The Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations Study Circulation 2022, 146: a9447-a9447. DOI: 10.1161/circ.146.suppl_1.9447.
• Quantification of intramyocardial blood volume using 99mTc-RBC SPECT/CT: a pilot human studyYousefi H, Shi L, Soufer A, Tsatkin V, Bruni W, Avendano R, Greco K, McMahon D, Thorn S, Miller E, Sinusas A, Liu C. Quantification of intramyocardial blood volume using 99mTc-RBC SPECT/CT: a pilot human study Journal Of Nuclear Cardiology 2022, 30: 292-297. PMID: 36319815, DOI: 10.1007/s12350-022-03123-0.
• PET Myocardial Blood Flow for Post-transplant Surveillance and Cardiac Allograft Vasculopathy in Heart Transplant RecipientsFeher A, Miller EJ. PET Myocardial Blood Flow for Post-transplant Surveillance and Cardiac Allograft Vasculopathy in Heart Transplant Recipients Current Cardiology Reports 2022, 24: 1865-1871. PMID: 36279035, DOI: 10.1007/s11886-022-01804-3.
• Direct Risk Assessment From Myocardial Perfusion Imaging Using Explainable Deep LearningSingh A, Miller RJH, Otaki Y, Kavanagh P, Hauser MT, Tzolos E, Kwiecinski J, Van Kriekinge S, Wei CC, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Huang C, Han D, Dey D, Berman DS, Slomka PJ. Direct Risk Assessment From Myocardial Perfusion Imaging Using Explainable Deep Learning JACC Cardiovascular Imaging 2022, 16: 209-220. PMID: 36274041, DOI: 10.1016/j.jcmg.2022.07.017.
• Deep Learning Coronary Artery Calcium Scores from SPECT/CT Attenuation Maps Improve Prediction of Major Adverse Cardiac Events.Miller R, Pieszko K, Shanbhag A, Feher A, Lemley M, Killekar A, Kavanagh PB, Van Kriekinge SD, Liang JX, Huang C, Miller EJ, Bateman T, Berman DS, Dey D, Slomka PJ. Deep Learning Coronary Artery Calcium Scores from SPECT/CT Attenuation Maps Improve Prediction of Major Adverse Cardiac Events. Journal Of Nuclear Medicine 2022, 64: 652-658. PMID: 36207138, PMCID: PMC10071789, DOI: 10.2967/jnumed.122.264423.
• Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT imagesMiller RJH, Singh A, Otaki Y, Tamarappoo BK, Kavanagh P, Parekh T, Hu LH, Gransar H, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli MF, Liang JX, Dey D, Berman DS, Slomka PJ. Mitigating bias in deep learning for diagnosis of coronary artery disease from myocardial perfusion SPECT images European Journal Of Nuclear Medicine And Molecular Imaging 2022, 50: 387-397. PMID: 36194270, PMCID: PMC10042590, DOI: 10.1007/s00259-022-05972-w.
• Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imagingFeher A, Pieszko K, Miller R, Lemley M, Shanbhag A, Huang C, Miras L, Liu YH, Sinusas AJ, Miller EJ, Slomka PJ. Integration of coronary artery calcium scoring from CT attenuation scans by machine learning improves prediction of adverse cardiovascular events in patients undergoing SPECT/CT myocardial perfusion imaging Journal Of Nuclear Cardiology 2022, 30: 590-603. PMID: 36195826, DOI: 10.1007/s12350-022-03099-x.
• Unsupervised machine learning improves risk stratification of patients with visual normal SPECT myocardial perfusion imaging assessmentsBednarski B, Williams M, Pieszko K, Miller R, Huang C, Kwiecinski J, Sharir T, Di Carli M, Fish M, Ruddy T, Hasuer T, Miller E, Acampa W, Berman D, Slomka P. Unsupervised machine learning improves risk stratification of patients with visual normal SPECT myocardial perfusion imaging assessments European Heart Journal 2022, 43 DOI: 10.1093/eurheartj/ehac544.300.
• DuDoSS: Deep‐learning‐based dual‐domain sinogram synthesis from sparsely sampled projections of cardiac SPECTChen X, Zhou B, Xie H, Miao T, Liu H, Holler W, Lin M, Miller EJ, Carson RE, Sinusas AJ, Liu C. DuDoSS: Deep‐learning‐based dual‐domain sinogram synthesis from sparsely sampled projections of cardiac SPECT Medical Physics 2022, 50: 89-103. PMID: 36048541, PMCID: PMC9868054, DOI: 10.1002/mp.15958.
• Deep Learning-Based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT.Shanbhag AD, Miller RJH, Pieszko K, Lemley M, Kavanagh P, Feher A, Miller EJ, Sinusas AJ, Kaufmann PA, Han D, Huang C, Liang JX, Berman DS, Dey D, Slomka PJ. Deep Learning-Based Attenuation Correction Improves Diagnostic Accuracy of Cardiac SPECT. Journal Of Nuclear Medicine 2022, 64: 472-478. PMID: 36137759, PMCID: PMC10071806, DOI: 10.2967/jnumed.122.264429.
• Deep Learning of Coronary Calcium Scores From PET/CT Attenuation Maps Accurately Predicts Adverse Cardiovascular EventsPieszko K, Shanbhag A, Killekar A, Miller RJH, Lemley M, Otaki Y, Singh A, Kwiecinski J, Gransar H, Van Kriekinge SD, Kavanagh PB, Miller EJ, Bateman T, Liang JX, Berman DS, Dey D, Slomka PJ. Deep Learning of Coronary Calcium Scores From PET/CT Attenuation Maps Accurately Predicts Adverse Cardiovascular Events JACC Cardiovascular Imaging 2022, 16: 675-687. PMID: 36284402, DOI: 10.1016/j.jcmg.2022.06.006.
• 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imagingAl-Mallah MH, Bateman TM, Branch KR, Crean A, Gingold EL, Thompson RC, McKenney SE, Miller EJ, Murthy VL, Nieman K, Villines TC, Yester MV, Einstein AJ, Mahmarian JJ. 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging Journal Of Nuclear Cardiology 2022, 29: 3491-3535. PMID: 36056224, DOI: 10.1007/s12350-022-03089-z.
• Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM.Sperry BW, Bateman TM, Akin EA, Bravo PE, Chen W, Dilsizian V, Hyafil F, Khor YM, Miller RJH, Slart RHJA, Slomka P, Verberne H, Miller EJ, Liu C. Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM. Journal Of Nuclear Medicine 2022, jnumed.122.264311. PMID: 35863895, DOI: 10.2967/jnumed.122.264311.
• Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANMSperry BW, Bateman TM, Akin EA, Bravo PE, Chen W, Dilsizian V, Hyafil F, Khor YM, Miller RJH, Slart RHJA, Slomka P, Verberne H, Miller EJ, Liu C. Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM Journal Of Nuclear Cardiology 2022, 30: 626-652. PMID: 35864433, DOI: 10.1007/s12350-022-02985-8.
• Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information StatementMiller EJ, Campisi R, Shah NR, McMahon S, Cuddy S, Gallegos-Kattan C, Maurer MS, Damy T, Slart RHJA, Bhatia K, Einstein AJ. Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene diphosphonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: An ASNC Information Statement Journal Of Nuclear Cardiology 2022, 29: 2748-2760. PMID: 35838892, PMCID: PMC9285188, DOI: 10.1007/s12350-022-03059-5.
• Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Journal Of Cardiac Failure 2022, 28: e1-e4. PMID: 34217819, DOI: 10.1016/j.cardfail.2021.06.012.
• Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter StudyTamarappoo BK, Otaki Y, Sharir T, Hu LH, Gransar H, Einstein AJ, Fish MB, Ruddy TD, Kaufmann P, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Eisenberg E, Liang JX, Dey D, Berman DS, Slomka PJ. Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter Study Circulation Cardiovascular Imaging 2022, 15: e012741. PMID: 35727872, PMCID: PMC9307118, DOI: 10.1161/circimaging.121.012741.
• The Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain A Meta-AnalysisAgha AM, Pacor J, Grandhi GR, Mszar R, Khan SU, Parikh R, Agrawal T, Burt J, Blankstein R, Blaha MJ, Shaw LJ, Al-Mallah MH, Brackett A, Cainzos-Achirica M, Miller EJ, Nasir K. The Prognostic Value of CAC Zero Among Individuals Presenting With Chest Pain A Meta-Analysis JACC Cardiovascular Imaging 2022, 15: 1745-1757. PMID: 36202453, DOI: 10.1016/j.jcmg.2022.03.031.
• Machine learning to predict abnormal myocardial perfusion from pre-test featuresMiller RJH, Hauser MT, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Huang C, Liang JX, Han D, Dey D, Berman DS, Slomka PJ. Machine learning to predict abnormal myocardial perfusion from pre-test features Journal Of Nuclear Cardiology 2022, 29: 2393-2403. PMID: 35672567, PMCID: PMC9588501, DOI: 10.1007/s12350-022-03012-6.
• Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosisDamsky W, Wang A, Kim DJ, Young BD, Singh K, Murphy MJ, Daccache J, Clark A, Ayasun R, Ryu C, McGeary MK, Odell ID, Fazzone-Chettiar R, Pucar D, Homer R, Gulati M, Miller EJ, Bosenberg M, Flavell RA, King B. Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis Nature Communications 2022, 13: 3140. PMID: 35668129, PMCID: PMC9170782, DOI: 10.1038/s41467-022-30615-x.
• Characteristics of patients referred to a cardiovascular disease clinic for post-acute sequelae of SARS-CoV-2 infectionWang SY, Adejumo P, See C, Onuma OK, Miller EJ, Spatz ES. Characteristics of patients referred to a cardiovascular disease clinic for post-acute sequelae of SARS-CoV-2 infection American Heart Journal Plus Cardiology Research And Practice 2022, 18: 100176. PMID: 35856065, PMCID: PMC9277988, DOI: 10.1016/j.ahjo.2022.100176.
• Short-Term Outcomes After Myopericarditis Related to COVID-19 VaccinationPareek M, Steele J, Asnes J, Baldassarre L, Casale L, Desai N, Elder R, Faherty E, Ferguson I, Fishman R, Ghazizadeh Z, Glick L, Hall E, Khera R, Kokkinidis D, Kwan J, O’Marr J, Schussheim A, Tuohy E, Wang Y, Spatz E, Jacoby D, Miller E. Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination JACC Cardiovascular Imaging 2022, 15: 2002-2005. PMCID: PMC9094612, DOI: 10.1016/j.jcmg.2022.03.026.
• Short-Term Outcomes After Myopericarditis Related to COVID-19 VaccinationPareek M, Steele J, Asnes J, Baldassarre L, Casale L, Desai N, Elder R, Faherty E, Ferguson I, Fishman R, Ghazizadeh Z, Glick L, Hall E, Khera R, Kokkinidis D, Kwan J, O'Marr J, Schussheim A, Tuohy E, Wang Y, Spatz E, Jacoby D, Miller E. Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination JACC Cardiovascular Imaging 2022, 15: 2002-2005. PMID: 36357140, PMCID: PMC9094612, DOI: 10.1016/j.jcmg.2022.03.026.
• Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging.Miller RJH, Kuronuma K, Singh A, Otaki Y, Hayes S, Chareonthaitawee P, Kavanagh P, Parekh T, Tamarappoo BK, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Carli MD, Cadet S, Liang JX, Dey D, Berman DS, Slomka PJ. Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion Imaging. Journal Of Nuclear Medicine 2022, 63: 1768-1774. PMID: 35512997, PMCID: PMC9635672, DOI: 10.2967/jnumed.121.263686.
• Calcium scoring in low-dose ungated chest CT scans using convolutional long-short term memory networksPieszko K, Shanbhag A, Killekar A, Lemley M, Otaki Y, Kriekinge SV, Kavanagh P, Miller RJ, Miller EJ, Bateman T, Dey D, Berman D, Slomka P. Calcium scoring in low-dose ungated chest CT scans using convolutional long-short term memory networks Proceedings Of SPIE 2022, 12032: 120323a-120323a-7. PMID: 36277935, PMCID: PMC9585987, DOI: 10.1117/12.2613147.
• Handling missing values in machine learning to predict patient-specific risk of adverse cardiac events: Insights from REFINE SPECT registryRios R, Miller RJH, Manral N, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Van Kriekinge SD, Kavanagh PB, Parekh T, Liang JX, Dey D, Berman DS, Slomka PJ. Handling missing values in machine learning to predict patient-specific risk of adverse cardiac events: Insights from REFINE SPECT registry Computers In Biology And Medicine 2022, 145: 105449. PMID: 35381453, PMCID: PMC9117456, DOI: 10.1016/j.compbiomed.2022.105449.
• RACIAL DISPARITIES IN UNEXPLAINED LEFT VENTRICULAR HYPERTROPHYSingh A, Harris K, Jacoby D, Miller E. RACIAL DISPARITIES IN UNEXPLAINED LEFT VENTRICULAR HYPERTROPHY Journal Of The American College Of Cardiology 2022, 79: 469. DOI: 10.1016/s0735-1097(22)01460-7.
• UNEXPLAINED AMYLOID SCREENING AND TREATMENT DROP OFF IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHYHarris K, Jacoby D, Singh A, Burg M, Onuma O, Kattan C, Shi T, Miller E. UNEXPLAINED AMYLOID SCREENING AND TREATMENT DROP OFF IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Journal Of The American College Of Cardiology 2022, 79: 446. DOI: 10.1016/s0735-1097(22)01437-1.
• DEEP LEARNING FROM UNGATED LOW-DOSE CT ATTENUATION CORRECTION MAPS PREDICTS MAJOR ADVERSE CARDIAC EVENTS SIMILAR TO STANDARD CORONARY CALCIUM SCORESPieszko K, Shanbhag A, Killekar A, Miller R, Lemley M, Hyun M, Singh A, Otaki Y, Van Kriekinge S, Kavanagh P, Gransar H, Miller E, Bateman T, Dey D, Berman D, Slomka P. DEEP LEARNING FROM UNGATED LOW-DOSE CT ATTENUATION CORRECTION MAPS PREDICTS MAJOR ADVERSE CARDIAC EVENTS SIMILAR TO STANDARD CORONARY CALCIUM SCORES Journal Of The American College Of Cardiology 2022, 79: 1227. DOI: 10.1016/s0735-1097(22)02218-5.
• Direct and indirect strategies of deep-learning-based attenuation correction for general purpose and dedicated cardiac SPECTChen X, Zhou B, Xie H, Shi L, Liu H, Holler W, Lin M, Liu YH, Miller EJ, Sinusas AJ, Liu C. Direct and indirect strategies of deep-learning-based attenuation correction for general purpose and dedicated cardiac SPECT European Journal Of Nuclear Medicine And Molecular Imaging 2022, 49: 3046-3060. PMID: 35169887, PMCID: PMC9253078, DOI: 10.1007/s00259-022-05718-8.
• Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registryHan D, Rozanski A, Miller RJH, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Dey D, Berman DS, Slomka PJ. Prevalence and predictors of automatically quantified myocardial ischemia within a multicenter international registry Journal Of Nuclear Cardiology 2022, 29: 3221-3232. PMID: 35174442, PMCID: PMC9378748, DOI: 10.1007/s12350-021-02829-x.
• Can We Manage Presymptomatic TTR V142I Related Risk?Murray MF, Miller EJ. Can We Manage Presymptomatic TTR V142I Related Risk? JACC. Heart Failure 2022, 10: 139-141. PMID: 35115087, DOI: 10.1016/j.jchf.2021.10.009.
• Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathyHiggins AY, Annapureddy AR, Wang Y, Minges KE, Bellumkonda L, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Risk and predictors of mortality after implantable cardioverter-defibrillator implantation in patients with sarcoid cardiomyopathy American Heart Journal 2021, 246: 21-31. PMID: 34968442, DOI: 10.1016/j.ahj.2021.12.011.
• Data Management and Network Architecture Effect on Performance Variability in Direct Attenuation Correction via Deep Learning for Cardiac SPECT: A Feasibility StudyTorkaman M, Yang J, Shi L, Wang R, Miller EJ, Sinusas AJ, Liu C, Gullberg GT, Seo Y. Data Management and Network Architecture Effect on Performance Variability in Direct Attenuation Correction via Deep Learning for Cardiac SPECT: A Feasibility Study IEEE Transactions On Radiation And Plasma Medical Sciences 2021, 6: 755-765. PMID: 36059429, PMCID: PMC9438341, DOI: 10.1109/trpms.2021.3138372.
• The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic transthyretin expressionPathak GA, De Lillo A, Wendt FR, De Angelis F, Koller D, Mendoza B, Jacoby D, Miller EJ, Buxbaum JN, Polimanti R. The integration of genetically-regulated transcriptomics and electronic health records highlights a pattern of medical outcomes related to increased hepatic transthyretin expression Amyloid 2021, 29: 110-119. PMID: 34935565, PMCID: PMC9213571, DOI: 10.1080/13506129.2021.2018678.
• Automatic Inter-Frame Patient Motion Correction for Dynamic Cardiac PET Using Deep LearningShi L, Lu Y, Dvornek N, Weyman CA, Miller EJ, Sinusas AJ, Liu C. Automatic Inter-Frame Patient Motion Correction for Dynamic Cardiac PET Using Deep Learning IEEE Transactions On Medical Imaging 2021, 40: 3293-3304. PMID: 34018932, PMCID: PMC8670362, DOI: 10.1109/tmi.2021.3082578.
• Abstract 11639: Characteristics of Patients Referred to a Cardiovascular Disease Clinic for Post-Acute Sequelae of SARS-CoV-2 InfectionWang S, Adejumo P, Onuma O, Miller E, Spatz E. Abstract 11639: Characteristics of Patients Referred to a Cardiovascular Disease Clinic for Post-Acute Sequelae of SARS-CoV-2 Infection Circulation 2021, 144: a11639-a11639. DOI: 10.1161/circ.144.suppl_1.11639.
• Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT RegistryHan D, Rozanski A, Gransar H, Tzolos E, Miller RJH, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Hu LH, Dey D, Berman DS, Slomka PJ. Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry Journal Of Nuclear Cardiology 2021, 29: 3003-3014. PMID: 34757571, PMCID: PMC9085969, DOI: 10.1007/s12350-021-02810-8.
• Potential novel imaging targets of inflammation in cardiac sarcoidosisPark J, Young BD, Miller EJ. Potential novel imaging targets of inflammation in cardiac sarcoidosis Journal Of Nuclear Cardiology 2021, 29: 2171-2187. PMID: 34734365, DOI: 10.1007/s12350-021-02838-w.
• Post-reconstruction attenuation correction for SPECT myocardium perfusion imaging facilitated by deep learning-based attenuation map generationLiu H, Wu J, Shi L, Liu Y, Miller E, Sinusas A, Liu YH, Liu C. Post-reconstruction attenuation correction for SPECT myocardium perfusion imaging facilitated by deep learning-based attenuation map generation Journal Of Nuclear Cardiology 2021, 29: 2881-2892. PMID: 34671940, DOI: 10.1007/s12350-021-02817-1.
• Impact of age, sex, and cardiac size on the diagnostic performance of myocardial perfusion single-photon emission computed tomography: insights from the REFINE SPECT registryRandazzo M, Elias P, Poterucha T, Sharir T, Fish M, Ruddy T, Kaufmann P, Sinusas A, Miller E, Bateman T, Dorbala S, Di Carli M, Berman D, Slomka P, Einstein A. Impact of age, sex, and cardiac size on the diagnostic performance of myocardial perfusion single-photon emission computed tomography: insights from the REFINE SPECT registry European Heart Journal 2021, 42: ehab724.0254. DOI: 10.1093/eurheartj/ehab724.0254.
• Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET ImagingYoung BD, Moreland H, Oatmen KE, Freeburg LA, Shahab Z, Herzog E, Miller EJ, Spinale FG. Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging International Heart Journal 2021, 62: 21-164. PMID: 34544982, DOI: 10.1536/ihj.21-164.
• Association Between Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography Imaging and Adverse Events in Patients With Autoimmune Rheumatic DiseaseFeher A, Boutagy NE, Oikonomou EK, Liu YH, Miller EJ, Sinusas AJ, Hinchcliff M. Association Between Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography Imaging and Adverse Events in Patients With Autoimmune Rheumatic Disease Circulation Cardiovascular Imaging 2021, 14: e012208. PMID: 34503339, PMCID: PMC8475774, DOI: 10.1161/circimaging.120.012208.
• Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2021, 28: 1769-1774. PMID: 34196911, DOI: 10.1007/s12350-020-02455-z.
• Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2021, 28: 1761-1762. PMID: 34259978, DOI: 10.1007/s12350-021-02711-w.
• Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. Correction to: ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2021, 28: 1763-1767. PMID: 34279803, DOI: 10.1007/s12350-021-02712-9.
• Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT RegistryKuronuma K, Miller RJH, Otaki Y, Van Kriekinge SD, Diniz MA, Sharir T, Hu LH, Gransar H, Liang JX, Parekh T, Kavanagh PB, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT Registry Circulation Cardiovascular Imaging 2021, 14: e012386. PMID: 34281372, PMCID: PMC8978932, DOI: 10.1161/circimaging.120.012386.
• Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography/Computed Tomography in Patients With Systemic Sclerosis.Feher A, Boutagy NE, Oikonomou EK, Thorn S, Liu YH, Miller EJ, Sinusas AJ, Hinchcliff M. Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography/Computed Tomography in Patients With Systemic Sclerosis. The Journal Of Rheumatology 2021, 48: 1574-1582. PMID: 34266986, PMCID: PMC10275580, DOI: 10.3899/jrheum.210040.
• Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry.Rios R, Miller RJH, Hu LH, Otaki Y, Singh A, Diniz M, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, DiCarli M, Van Kriekinge S, Kavanagh P, Parekh T, Liang JX, Dey D, Berman DS, Slomka P. Determining a minimum set of variables for machine learning cardiovascular event prediction: results from REFINE SPECT registry. Cardiovascular Research 2021, 118: 2152-2164. PMID: 34259870, PMCID: PMC9302886, DOI: 10.1093/cvr/cvab236.
• Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery DiseaseOtaki Y, Singh A, Kavanagh P, Miller RJH, Parekh T, Tamarappoo BK, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Cadet S, Liang JX, Dey D, Berman DS, Slomka PJ. Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery Disease JACC Cardiovascular Imaging 2021, 15: 1091-1102. PMID: 34274267, PMCID: PMC9020794, DOI: 10.1016/j.jcmg.2021.04.030.
• Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECTEisenberg E, Miller RJH, Hu LH, Rios R, Betancur J, Azadani P, Han D, Sharir T, Einstein AJ, Bokhari S, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Otaki Y, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT Journal Of Nuclear Cardiology 2021, 29: 2295-2307. PMID: 34228341, PMCID: PMC9020793, DOI: 10.1007/s12350-021-02698-4.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Circulation. Cardiovascular Imaging 2021, 14: e000030. PMID: 34196222, DOI: 10.1161/HCI.0000000000000030.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circulation. Cardiovascular Imaging 2021, 14: e000029. PMID: 34196223, DOI: 10.1161/HCI.0000000000000029.
• CT-free attenuation correction for dedicated cardiac SPECT using a 3D dual squeeze-and-excitation residual dense networkChen X, Zhou B, Shi L, Liu H, Pang Y, Wang R, Miller EJ, Sinusas AJ, Liu C. CT-free attenuation correction for dedicated cardiac SPECT using a 3D dual squeeze-and-excitation residual dense network Journal Of Nuclear Cardiology 2021, 29: 2235-2250. PMID: 34085168, DOI: 10.1007/s12350-021-02672-0.
• Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin UseWendt FR, Koller D, Pathak GA, Jacoby D, Miller EJ, Polimanti R. Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use Clinical Pharmacology & Therapeutics 2021, 110: 777-785. PMID: 33837531, PMCID: PMC8376807, DOI: 10.1002/cpt.2260.
• Non-steroidal treatment of cardiac sarcoidosis: A systematic reviewGallegos C, Oikonomou EK, Grimshaw A, Gulati M, Young BD, Miller EJ. Non-steroidal treatment of cardiac sarcoidosis: A systematic review IJC Heart & Vasculature 2021, 34: 100782. PMID: 33997256, PMCID: PMC8105294, DOI: 10.1016/j.ijcha.2021.100782.
• A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST).Oikonomou EK, Van Dijk D, Parise H, Suchard MA, de Lemos J, Antoniades C, Velazquez EJ, Miller EJ, Khera R. A phenomapping-derived tool to personalize the selection of anatomical vs. functional testing in evaluating chest pain (ASSIST). European Heart Journal 2021, 42: 2536-2548. PMID: 33881513, PMCID: PMC8488385, DOI: 10.1093/eurheartj/ehab223.
• Quantitation of Poststress Change in Ventricular Morphology Improves Risk StratificationMiller RJH, Sharir T, Otaki Y, Gransar H, Liang JX, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Quantitation of Poststress Change in Ventricular Morphology Improves Risk Stratification Journal Of Nuclear Medicine 2021, 62: 1582-1590. PMID: 33712535, PMCID: PMC8612345, DOI: 10.2967/jnumed.120.260141.
• Scintigraphie osseuse au 99mTc-DPD ou 99mTc-HMDP pour le diagnostic d’amylose cardiaque à transthyrétineHyafil F, Lairez O, de rédaction G, Dorbala S, Bokhari S, Glaudemans A, Miller E, Bullock-Palmer R, Slart R, Soman P, Thompson R, Verberne H, de réviseurs G, Jaroudi W, Einstein A, Gheysens O, Hyafil F. Scintigraphie osseuse au 99mTc-DPD ou 99mTc-HMDP pour le diagnostic d’amylose cardiaque à transthyrétine Nuklearmedizin - NuclearMedicine 2021, 45: 93-97. DOI: 10.1016/j.mednuc.2020.11.001.
• Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility StudyYang J, Shi L, Wang R, Miller EJ, Sinusas AJ, Liu C, Gullberg GT, Seo Y. Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study Journal Of Nuclear Medicine 2021, 62: 1645-1652. PMID: 33637586, PMCID: PMC8612332, DOI: 10.2967/jnumed.120.256396.
• Arrhythmias in Cardiac Sarcoidosis Bench to BedsideRosenfeld LE, Chung MK, Harding CV, Spagnolo P, Grunewald J, Appelbaum J, Sauer WH, Culver DA, Joglar JA, Lin BA, Jellis CL, Dickfeld TM, Kwon DH, Miller EJ, Cremer PC, Bogun F, Kron J, Bock A, Mehta D, Leis P, Siontis KC, Kaufman ES, Crawford T, Zimetbaum P, Zishiri ET, Singh JP, Ellenbogen KA, Chrispin J, Quadri S, Vincent LL, Patton KK, Kalbfleish S, Callahan TD, Murgatroyd F, Judson MA, Birnie D, Okada DR, Maulion C, Bhat P, Bellumkonda L, Blankstein R, Cheng RK, Farr MA, Estep JD. Arrhythmias in Cardiac Sarcoidosis Bench to Bedside Circulation Arrhythmia And Electrophysiology 2021, 14: e009203. PMID: 33591816, PMCID: PMC8142901, DOI: 10.1161/circep.120.009203.
• Direct Image-Based Attenuation Correction using Conditional Generative Adversarial Network for SPECT Myocardial Perfusion Imaging.Torkaman M, Yang J, Shi L, Wang R, Miller EJ, Sinusas AJ, Liu C, Gullberg GT, Seo Y. Direct Image-Based Attenuation Correction using Conditional Generative Adversarial Network for SPECT Myocardial Perfusion Imaging. Proceedings Of SPIE 2021, 11600: 27. PMID: 33727759, PMCID: PMC7956874, DOI: 10.1117/12.2580922.
• Diagnostic accuracy of stress-only myocardial perfusion SPECT improved by deep learningLiu H, Wu J, Miller EJ, Liu C, Yaqiang, Liu, Liu YH. Diagnostic accuracy of stress-only myocardial perfusion SPECT improved by deep learning European Journal Of Nuclear Medicine And Molecular Imaging 2021, 48: 2793-2800. PMID: 33511425, DOI: 10.1007/s00259-021-05202-9.
• Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistakeGerber J, Miller EJ. Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake Journal Of Nuclear Cardiology 2021, 28: 503-506. PMID: 33442822, DOI: 10.1007/s12350-020-02503-8.
• Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registryKlein E, Miller RJH, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Otaki Y, Gransar H, Liang JX, Dey D, Berman DS, Slomka PJ. Automated quantitative analysis of CZT SPECT stratifies cardiovascular risk in the obese population: Analysis of the REFINE SPECT registry Journal Of Nuclear Cardiology 2020, 29: 727-736. PMID: 32929639, PMCID: PMC8497048, DOI: 10.1007/s12350-020-02334-7.
• Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid CardiomyopathyHiggins AY, Annapureddy AR, Wang Y, Minges KE, Lampert R, Rosenfeld LE, Jacoby DL, Curtis JP, Miller EJ, Freeman JV. Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy Journal Of The American Heart Association 2020, 9: e016038. PMID: 32867553, PMCID: PMC7726970, DOI: 10.1161/jaha.120.016038.
• Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified IschemiaAzadani PN, Miller RJH, Sharir T, Diniz MA, Hu LH, Otaki Y, Gransar H, Liang JX, Eisenberg E, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia JACC Cardiovascular Imaging 2020, 14: 644-653. PMID: 32828784, PMCID: PMC7987223, DOI: 10.1016/j.jcmg.2020.05.039.
• Quantification of myocardial blood flow (MBF) and reserve (MFR) incorporated with a novel segmentation approach: Assessments of quantitative precision and the lower limit of normal MBF and MFR in patientsLiu H, Thorn S, Wu J, Fazzone-Chettiar R, Sandoval V, Miller EJ, Sinusas AJ, Liu YH. Quantification of myocardial blood flow (MBF) and reserve (MFR) incorporated with a novel segmentation approach: Assessments of quantitative precision and the lower limit of normal MBF and MFR in patients Journal Of Nuclear Cardiology 2020, 28: 1236-1248. PMID: 32715416, DOI: 10.1007/s12350-020-02278-y.
• Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT.Hu LH, Miller RJH, Sharir T, Commandeur F, Rios R, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Eisenberg E, Dey D, Berman DS, Slomka PJ. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECT. European Heart Journal - Cardiovascular Imaging 2020, 22: 705-714. PMID: 32533137, DOI: 10.1093/ehjci/jeaa134.
• Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion ImagingMurthy VL, Bateman TM, Chen W, Malhotra S, Miller EJ, Ruddy TD, Dilsizian V. Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging Journal Of Nuclear Medicine 2020, 61: 962-964. PMID: 32611712, PMCID: PMC7383082, DOI: 10.2967/jnumed.119.245399.
• Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging.Murthy VL, Bateman TM, Chen W, Malhotra S, Miller E, Ruddy T, Dilsizian V. Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging. Journal Of Nuclear Medicine 2020, jnumed.120.245399. PMID: 32513904, DOI: 10.2967/jnumed.120.245399.
• Advances in PET-Based Cardiac Amyloid RadiotracersGallegos C, Miller EJ. Advances in PET-Based Cardiac Amyloid Radiotracers Current Cardiology Reports 2020, 22: 40. PMID: 32430600, DOI: 10.1007/s11886-020-01284-3.
• Feasibility study of PET dynamic imaging of [18F]DHMT for quantification of reactive oxygen species in the myocardium of large animalsWu J, Boutagy NE, Cai Z, Lin SF, Zheng MQ, Feher A, Stendahl JC, Kapinos M, Gallezot JD, Liu H, Mulnix T, Zhang W, Lindemann M, Teng JK, Miller EJ, Huang Y, Carson RE, Sinusas AJ, Liu C. Feasibility study of PET dynamic imaging of [18F]DHMT for quantification of reactive oxygen species in the myocardium of large animals Journal Of Nuclear Cardiology 2020, 29: 216-225. PMID: 32415628, PMCID: PMC7666654, DOI: 10.1007/s12350-020-02184-3.
• Incidental finding of COVID-19 pulmonary infiltrates on SPECT/CT attenuation correction CTHindle-Katel W, Oen-Hsiao J, Lussnig E, Miller EJ. Incidental finding of COVID-19 pulmonary infiltrates on SPECT/CT attenuation correction CT Journal Of Nuclear Cardiology 2020, 27: 1385-1386. PMID: 32394407, PMCID: PMC7213942, DOI: 10.1007/s12350-020-02178-1.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2020, 27: 659-673. PMID: 31468377, DOI: 10.1007/s12350-019-01761-5.
• PROGNOSTIC IMPACT OF DIABETES IN PATIENTS WITH OR WITHOUT KNOWN CORONARY ARTERY DISEASE, RESULTS FROM THE REFINE SPECT REGISTRYHan D, Otaki Y, Tzolos E, Klein E, Gransar H, Sharir T, Einstein A, Fish M, Ruddy T, Kaufmann P, Sinusas A, Miller E, Bateman T, Dorbala S, Di Carli M, Liang J, Dey D, Berman D, Slomka P. PROGNOSTIC IMPACT OF DIABETES IN PATIENTS WITH OR WITHOUT KNOWN CORONARY ARTERY DISEASE, RESULTS FROM THE REFINE SPECT REGISTRY Journal Of The American College Of Cardiology 2020, 75: 1796. DOI: 10.1016/s0735-1097(20)32423-2.
• IMPAIRED CORONARY FLOW RESERVE ON 82RUBIDIUM POSITRON EMISSION TOMOGRAPHY IMAGING PREDICTS ADVERSE EVENTS IN PATIENTS WITH AUTOIMMUNE DISEASEFeher A, Boutagy N, Oikonomou E, Miller E, Sinusas A, Hinchcliff M. IMPAIRED CORONARY FLOW RESERVE ON 82RUBIDIUM POSITRON EMISSION TOMOGRAPHY IMAGING PREDICTS ADVERSE EVENTS IN PATIENTS WITH AUTOIMMUNE DISEASE Journal Of The American College Of Cardiology 2020, 75: 1726. DOI: 10.1016/s0735-1097(20)32353-6.
• HIDING IN PLAIN SITE: SYSTEMIC INVOLVEMENT IN A PATIENT WITH ATTR CARDIAC AMYLOIDOSISJoodi G, Foley R, Meng J, Miller E, Kattan C. HIDING IN PLAIN SITE: SYSTEMIC INVOLVEMENT IN A PATIENT WITH ATTR CARDIAC AMYLOIDOSIS Journal Of The American College Of Cardiology 2020, 75: 3106. DOI: 10.1016/s0735-1097(20)33733-5.
• Treatment of Multiorgan Sarcoidosis With TofacitinibDamsky W, Young BD, Sloan B, Miller EJ, Obando JA, King B. Treatment of Multiorgan Sarcoidosis With Tofacitinib ACR Open Rheumatology 2020, 2: 106-109. PMID: 31916703, PMCID: PMC7011417, DOI: 10.1002/acr2.11112.
• Complex cellular physiology underlies the use of FDG-PET imaging in investigating post-infarction remodelingMiller EJ. Complex cellular physiology underlies the use of FDG-PET imaging in investigating post-infarction remodeling Journal Of Nuclear Cardiology 2020, 27: 532-533. PMID: 31907858, DOI: 10.1007/s12350-019-02008-z.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Journal Of Nuclear Cardiology : Official Publication Of The American Society Of Nuclear Cardiology 2019, 26: 2065-2123. PMID: 31468376, DOI: 10.1007/s12350-019-01760-6.
• Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT RegistryHan D, Rozanski A, Gransar H, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Liang JX, Hu LH, Germano G, Dey D, Berman DS, Slomka PJ. Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT Registry Diabetes Care 2019, 43: 453-459. PMID: 31776140, PMCID: PMC6971784, DOI: 10.2337/dc19-1360.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization. Journal Of Cardiac Failure 2019, 25: 854-865. PMID: 31473267, DOI: 10.1016/j.cardfail.2019.08.002.
• ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging.Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, Fontana M, Gheysens O, Gillmore JD, Glaudemans AWJM, Hanna MA, Hazenberg BPC, Kristen AV, Kwong RY, Maurer MS, Merlini G, Miller EJ, Moon JC, Murthy VL, Quarta CC, Rapezzi C, Ruberg FL, Shah SJ, Slart RHJA, Verberne HJ, Bourque JM. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Journal Of Cardiac Failure 2019, 25: e1-e39. PMID: 31473268, DOI: 10.1016/j.cardfail.2019.08.001.
• New approach for quantification of left ventricular function from low-dose gated bloodpool SPECT: Validation and comparison with conventional methods in patientsLiu YH, Fazzone-Chettiar R, Sandoval V, Tsatkin V, Miller EJ, Sinusas AJ. New approach for quantification of left ventricular function from low-dose gated bloodpool SPECT: Validation and comparison with conventional methods in patients Journal Of Nuclear Cardiology 2019, 28: 939-950. PMID: 31338796, DOI: 10.1007/s12350-019-01823-8.
• Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry.Hu LH, Betancur J, Sharir T, Einstein AJ, Bokhari S, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Germano G, Commandeur F, Liang JX, Otaki Y, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry. European Heart Journal - Cardiovascular Imaging 2019, 21: 549-559. PMID: 31317178, PMCID: PMC7167744, DOI: 10.1093/ehjci/jez177.
• Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry.Miller RJH, Hu LH, Gransar H, Betancur J, Eisenberg E, Otaki Y, Sharir T, Fish MB, Ruddy TD, Dorbala S, Carli MD, Einstein AJ, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman T, Germano G, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registry. European Heart Journal - Cardiovascular Imaging 2019, 21: 567-575. PMID: 31302679, PMCID: PMC7167750, DOI: 10.1093/ehjci/jez172.
• 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects Results From REFINE SPECTOtaki Y, Betancur J, Sharir T, Hu LH, Gransar H, Liang JX, Azadani PN, Einstein AJ, Fish MB, Ruddy TD, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Tamarappoo BK, Germano G, Dey D, Berman DS, Slomka PJ. 5-Year Prognostic Value of Quantitative Versus Visual MPI in Subtle Perfusion Defects Results From REFINE SPECT JACC Cardiovascular Imaging 2019, 13: 774-785. PMID: 31202740, PMCID: PMC6899217, DOI: 10.1016/j.jcmg.2019.02.028.
• Advanced Cardiac Imaging and the Complexity of Diagnosing Cardiac SarcoidosisMiller EJ, Jacoby D. Advanced Cardiac Imaging and the Complexity of Diagnosing Cardiac Sarcoidosis Circulation Cardiovascular Imaging 2019, 12: e009275. PMID: 31177819, DOI: 10.1161/circimaging.119.009275.
• P289SPECT camera head configuration, acquisition time, and resolution recovery processing impact image defect size quantificationStendahl J, Weyman C, Liu Y, Liu C, Miller E, Sinusas A. P289SPECT camera head configuration, acquisition time, and resolution recovery processing impact image defect size quantification European Heart Journal - Cardiovascular Imaging 2019, 20 DOI: 10.1093/ehjci/jez148.018.
• Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registryHu LH, Sharir T, Miller RJH, Einstein AJ, Fish MB, Ruddy TD, Dorbala S, Di Carli M, Kaufmann PA, Sinusas AJ, Miller EJ, Bateman TM, Betancur J, Germano G, Liang JX, Commandeur F, Azadani PN, Gransar H, Otaki Y, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registry Journal Of Nuclear Cardiology 2019, 27: 1180-1189. PMID: 31087268, PMCID: PMC6851400, DOI: 10.1007/s12350-019-01730-y.
• Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac SarcoidosisAlvi RM, Young BD, Shahab Z, Pan H, Winkler J, Herzog E, Miller EJ. Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis JACC Cardiovascular Imaging 2019, 12: 1284-1287. PMID: 30846271, DOI: 10.1016/j.jcmg.2019.01.011.
• PREDICTING MAJOR ADVERSE CARDIAC EVENTS WITH COX NEURAL NETWORKS: RESULTS FROM THE REFINE SPECT REGISTRYSlomka P, Betancur J, Otaki Y, Commandeur F, Sharir T, Einstein A, Fish M, Ruddy T, Kaufmann P, Sinusas A, Miller E, Bateman T, Dorbala S, Di Carli M, Diniz M, Germano G, Dey D, Cooper L, Berman D. PREDICTING MAJOR ADVERSE CARDIAC EVENTS WITH COX NEURAL NETWORKS: RESULTS FROM THE REFINE SPECT REGISTRY Journal Of The American College Of Cardiology 2019, 73: 1432. DOI: 10.1016/s0735-1097(19)32038-8.
• TRANSIENT ISCHEMIC DILATATION IS INDEPENDENTLY ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENTS IN PATIENTS WITHOUT ISCHEMIA: ANALYSIS OF THE REFINE REGISTRYMiller R, Hu L, Gransar H, Betancur J, Eisenberg E, Sharir T, Fish M, Ruddy T, Dorbala S, Di Carli M, Einstein A, Kaufmann P, Sinusas A, Miller E, Bateman T, Tamarappoo B, Dey D, Berman D, Slomka P. TRANSIENT ISCHEMIC DILATATION IS INDEPENDENTLY ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENTS IN PATIENTS WITHOUT ISCHEMIA: ANALYSIS OF THE REFINE REGISTRY Journal Of The American College Of Cardiology 2019, 73: 1454. DOI: 10.1016/s0735-1097(19)32060-1.
• SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC AMYLOIDOSISHiggins A, Annapureddy A, Wang Y, Minges K, Lampert R, Rosenfeld L, Jacoby D, Curtis J, Miller E, Freeman J. SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC AMYLOIDOSIS Journal Of The American College Of Cardiology 2019, 73: 694. DOI: 10.1016/s0735-1097(19)31302-6.
• SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC SARCOIDOSISHiggins A, Annapureddy A, Wang Y, Minges K, Lampert R, Rosenfeld L, Jacoby D, Curtis J, Miller E, Freeman J. SURVIVAL FOLLOWING IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION IN PATIENTS WITH CARDIAC SARCOIDOSIS Journal Of The American College Of Cardiology 2019, 73: 306. DOI: 10.1016/s0735-1097(19)30914-3.
• REPRODUCIBILITY AND OPTIMIZATION OF 18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATION OF CARDIAC SARCOIDOSISAlvi R, Young B, Shahab Z, Pan H, Winkler J, Herzog E, Miller E. REPRODUCIBILITY AND OPTIMIZATION OF 18-FLUORO-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATION OF CARDIAC SARCOIDOSIS Journal Of The American College Of Cardiology 2019, 73: 1659. DOI: 10.1016/s0735-1097(19)32265-x.
• INTER-STUDY AGREEMENT BETWEEN RB-82 PET MYOCARDIAL BLOOD FLOW AND THERMODILUTION INDEX OF MICROCIRCULATORY RESISTANCE FOR EVALUATION OF CORONARY MICROVASCULAR DISEASEKattan C, Shah S, Pfau S, Miller E. INTER-STUDY AGREEMENT BETWEEN RB-82 PET MYOCARDIAL BLOOD FLOW AND THERMODILUTION INDEX OF MICROCIRCULATORY RESISTANCE FOR EVALUATION OF CORONARY MICROVASCULAR DISEASE Journal Of The American College Of Cardiology 2019, 73: 1571. DOI: 10.1016/s0735-1097(19)32177-1.
• Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosisSharp MB, Soufer A, Abdelmessih M, Rosenfeld LE, Baldassarre LA, Miller EJ. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis Journal Of Nuclear Cardiology 2019, 27: 688-690. PMID: 30737635, DOI: 10.1007/s12350-019-01640-z.
• PET-Based Imaging of Ischemic Heart DiseaseChen K, Miller EJ, Sadeghi MM. PET-Based Imaging of Ischemic Heart Disease PET Clinics 2019, 14: 211-221. PMID: 30826019, PMCID: PMC6426655, DOI: 10.1016/j.cpet.2018.12.003.
• Chapter 9 Cardiac Sarcoidosis Questions for the ClinicianVarghese M, Shahab Z, Miller E. Chapter 9 Cardiac Sarcoidosis Questions for the Clinician 2019, 105-113. DOI: 10.1016/b978-0-323-54429-0.00009-4.
• New Method for Quantification of the Left Ventricular Function from Low-dose Equilibrium Radionuclide Angiocardiography: Comparisons with Conventional Methods in PatientsLiu Y, Tsatkin V, Fazzone-Chettiar R, Miller E, Sinusas A. New Method for Quantification of the Left Ventricular Function from Low-dose Equilibrium Radionuclide Angiocardiography: Comparisons with Conventional Methods in Patients 2018, 00: 1-3. DOI: 10.1109/nssmic.2018.8824749.
• Serial Assessment of Coronary Flow Reserve by Rubidium-82 Positron Emission Tomography Predicts Mortality in Heart Transplant RecipientsFeher A, Srivastava A, Quail MA, Boutagy NE, Khanna P, Wilson L, Miller EJ, Liu YH, Lee F, Sinusas AJ. Serial Assessment of Coronary Flow Reserve by Rubidium-82 Positron Emission Tomography Predicts Mortality in Heart Transplant Recipients JACC Cardiovascular Imaging 2018, 13: 109-120. PMID: 30343093, PMCID: PMC6461525, DOI: 10.1016/j.jcmg.2018.08.025.
• Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter StudyBetancur J, Hu LH, Commandeur F, Sharir T, Einstein AJ, Fish MB, Ruddy TD, Kaufmann P, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Germano G, Otaki Y, Liang JX, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study Journal Of Nuclear Medicine 2018, 60: 664-670. PMID: 30262516, PMCID: PMC6495237, DOI: 10.2967/jnumed.118.213538.
• Specific Pro-Inflammatory Signaling Pathways are Induced in Patients with Cardiac Sarcoidosis; Potential Prognostic/Therapeutic ApplicationsYoung B, Oatmen K, Freeburg L, Zellars K, Sapp A, Herzog E, Miller E, Spinale F. Specific Pro-Inflammatory Signaling Pathways are Induced in Patients with Cardiac Sarcoidosis; Potential Prognostic/Therapeutic Applications Journal Of Cardiac Failure 2018, 24: s10. DOI: 10.1016/j.cardfail.2018.07.033.
• Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT)Slomka PJ, Betancur J, Liang JX, Otaki Y, Hu LH, Sharir T, Dorbala S, Di Carli M, Fish MB, Ruddy TD, Bateman TM, Einstein AJ, Kaufmann PA, Miller EJ, Sinusas AJ, Azadani PN, Gransar H, Tamarappoo BK, Dey D, Berman DS, Germano G. Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT) Journal Of Nuclear Cardiology 2018, 27: 1010-1021. PMID: 29923104, PMCID: PMC6301135, DOI: 10.1007/s12350-018-1326-4.
• In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, 18F-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in RodentsBoutagy NE, Wu J, Cai Z, Zhang W, Booth CJ, Kyriakides TC, Pfau D, Mulnix T, Liu Z, Miller EJ, Young LH, Carson RE, Huang Y, Liu C, Sinusas AJ. In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, 18F-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in Rodents JACC Basic To Translational Science 2018, 3: 378-390. PMID: 30062224, PMCID: PMC6058999, DOI: 10.1016/j.jacbts.2018.02.003.
• Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT A Multicenter StudyBetancur J, Commandeur F, Motlagh M, Sharir T, Einstein AJ, Bokhari S, Fish MB, Ruddy TD, Kaufmann P, Sinusas AJ, Miller EJ, Bateman TM, Dorbala S, Di Carli M, Germano G, Otaki Y, Tamarappoo BK, Dey D, Berman DS, Slomka PJ. Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT A Multicenter Study JACC Cardiovascular Imaging 2018, 11: 1654-1663. PMID: 29550305, PMCID: PMC6135711, DOI: 10.1016/j.jcmg.2018.01.020.
• SUV QUANTIFICATION OF 99MTC-PYP IMAGING IN TTR-CARDIAC AMYLOIDOSIS USING A CZT CAMERA: A NEW TOOL IN THE ARMAMENTARIUMSikanderkhel S, Liu Y, Liu C, Miller E. SUV QUANTIFICATION OF 99MTC-PYP IMAGING IN TTR-CARDIAC AMYLOIDOSIS USING A CZT CAMERA: A NEW TOOL IN THE ARMAMENTARIUM Journal Of The American College Of Cardiology 2018, 71: a1689. DOI: 10.1016/s0735-1097(18)32230-7.
• Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay From Symptom Onset to DiagnosisPapoutsidakis N, Miller EJ, Rodonski A, Jacoby D. Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay From Symptom Onset to Diagnosis Journal Of Cardiac Failure 2018, 24: 131-133. PMID: 29305186, DOI: 10.1016/j.cardfail.2017.12.005.
• Establishing an Evidence-Based Method to Diagnose Cardiac SarcoidosisMiller EJ, Culver DA. Establishing an Evidence-Based Method to Diagnose Cardiac Sarcoidosis Circulation Cardiovascular Imaging 2018, 11: e007408. PMID: 29335273, DOI: 10.1161/circimaging.117.007408.
• Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventionsVarghese M, Smiley D, Bellumkonda L, Rosenfeld LE, Zaret B, Miller EJ. Quantitative interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions Sarcoidosis, Vasculitis, And Diffuse Lung Diseases 2018, 35: 342-353. PMID: 32476922, PMCID: PMC7170132, DOI: 10.36141/svdld.v35i4.7342.
• Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET)Higgins AY, Taylor EP, Baldassarre LA, Miller EJ, Rosenfeld LE. Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET) Journal Of Nuclear Cardiology 2017, 25: 1869-1871. PMID: 29116563, DOI: 10.1007/s12350-017-1099-1.
• A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear CardiologySlart RHJA, Glaudemans AWJM, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, Jaber WA, Russell R, Gimelli A, Rouzet F, Hacker M, Gheysens O, Plein S, Miller EJ, Dorbala S, Donal E, Document Reading Group. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology Journal Of Nuclear Cardiology 2017, 25: 298-319. PMID: 29043557, DOI: 10.1007/s12350-017-1043-4.
• A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.Slart R, Glaudemans A, Lancellotti P, Hyafil F, Blankstein R, Schwartz R, Jaber W, Russell R, Gimelli A, Rouzet F, Hacker M, Gheysens O, Plein S, Miller E, Dorbala S, Donal E, Sciagra R, Bucerius J, Verberne H, Lindner O, Übleis C, Agostini D, Signore A, Edvardsen T, Neglia D, Beanlands R, Di Carli M, Chareonthaitawee P, Dilsizian V, Soman P, Habib G, Delgado V, Cardim N, Cosyns B, Flachskampf F, Gerber B, Haugaa K, Lombardi M, Masci P. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. European Heart Journal - Cardiovascular Imaging 2017, 18: 1073-1089. PMID: 28984894, DOI: 10.1093/ehjci/jex146.
• Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMRAlvi R, Miller EJ, Zonouz TH, Sandoval V, Tariq N, Lampert R, Sinusas AJ, Liu YH. Quantification and Determination of Normal 123I-Meta Iodobenzylguanidine Heart-to-Mediastinum Ratio (HMR) from Cardiac SPECT/CT and Correlation with Planar HMR Journal Of Nuclear Medicine 2017, 59: 652-658. PMID: 28916622, DOI: 10.2967/jnumed.117.197152.
• Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoringChareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring Journal Of Nuclear Cardiology 2017, 24: 1741-1758. PMID: 28770463, DOI: 10.1007/s12350-017-0978-9.
• Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy MonitoringChareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, Birnie DH, Chen ES, Cooper LT, Tung RH, White ES, Borges-Neto S, Di Carli MF, Gropler RJ, Ruddy TD, Schindler TH, Blankstein R, GROUP N, Bateman T, Cerqueira M, Dilsizian V, Heller G, Moller D, Osborne M, Sadeghi M, Soman P. Joint SNMMI–ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring Journal Of Nuclear Medicine 2017, 58: 1341-1353. PMID: 28765228, PMCID: PMC6944184, DOI: 10.2967/jnumed.117.196287.
• Up-regulation of Intracellular Calcium Handling Underlies the Recovery of Endotoxemic Cardiomyopathy in MiceMorse JC, Huang J, Khona N, Miller EJ, Siwik DA, Colucci WS, Hobai IA. Up-regulation of Intracellular Calcium Handling Underlies the Recovery of Endotoxemic Cardiomyopathy in Mice Anesthesiology 2017, 126: 1125-1138. PMID: 28410273, DOI: 10.1097/aln.0000000000001627.
• Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new techniqueGallegos C, Miller EJ. Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique Journal Of Nuclear Cardiology 2017, 25: 1568-1570. PMID: 28357811, DOI: 10.1007/s12350-017-0847-6.
• EFFUSIVE-CONSTRICTIVE PERICARDITIS IN A PATIENT WITH HYPEREOSINOPHILIC SYNDROMEDominguez Y, Emami H, Jacoby D, Miller E. EFFUSIVE-CONSTRICTIVE PERICARDITIS IN A PATIENT WITH HYPEREOSINOPHILIC SYNDROME Journal Of The American College Of Cardiology 2017, 69: 2368. DOI: 10.1016/s0735-1097(17)35757-1.
• Imaging Options in Cardiac Amyloidosis: Differentiating AL from ATTRPawar S, Haq M, Ruberg F, Miller E. Imaging Options in Cardiac Amyloidosis: Differentiating AL from ATTR Current Cardiovascular Imaging Reports 2017, 10: 1. DOI: 10.1007/s12410-017-9399-z.
• Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosisSalinaro F, Meier-Ewert HK, Miller EJ, Pandey S, Sanchorawala V, Berk JL, Seldin DC, Ruberg FL. Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis European Heart Journal - Cardiovascular Imaging 2016, 18: 1057-1064. PMID: 27965280, DOI: 10.1093/ehjci/jew298.
• Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac AmyloidosisCastano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, Dispenzieri A, Grogan M, Johnson G, Bokhari S, Maurer MS. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis JAMA Cardiology 2016, 1: 880-889. PMID: 27557400, DOI: 10.1001/jamacardio.2016.2839.
• Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?Haq M, Pawar S, Berk JL, Miller EJ, Ruberg FL. Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis? JACC Cardiovascular Imaging 2016, 10: 713-714. PMID: 27568122, PMCID: PMC5318295, DOI: 10.1016/j.jcmg.2016.06.003.
• The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosisAhmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis Journal Of Nuclear Cardiology 2016, 24: 413-424. PMID: 27457527, DOI: 10.1007/s12350-016-0490-7.
• Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisGillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis Circulation 2016, 133: 2404-2412. PMID: 27143678, DOI: 10.1161/circulationaha.116.021612.
• National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphyHarb SC, Haq M, Flood K, Guerrieri A, Passerell W, Jaber WA, Miller EJ. National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy Journal Of Nuclear Cardiology 2016, 24: 1094-1097. PMID: 27016106, DOI: 10.1007/s12350-016-0478-3.
• Visual identification of coronary calcifications on attenuation correction CT improves diagnostic accuracy of SPECT/CT myocardial perfusion imagingPatchett ND, Pawar S, Miller EJ. Visual identification of coronary calcifications on attenuation correction CT improves diagnostic accuracy of SPECT/CT myocardial perfusion imaging Journal Of Nuclear Cardiology 2016, 24: 711-720. PMID: 26850031, DOI: 10.1007/s12350-016-0395-5.
• Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet‐Induced Metabolic Heart DiseaseSverdlov AL, Elezaby A, Qin F, Behring JB, Luptak I, Calamaras TD, Siwik DA, Miller EJ, Liesa M, Shirihai OS, Pimentel DR, Cohen RA, Bachschmid MM, Colucci WS. Mitochondrial Reactive Oxygen Species Mediate Cardiac Structural, Functional, and Mitochondrial Consequences of Diet‐Induced Metabolic Heart Disease Journal Of The American Heart Association 2016, 5: e002555. PMID: 26755553, PMCID: PMC4859372, DOI: 10.1161/jaha.115.002555.
• Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic ChallengeMiller EJ, Calamaras T, Elezaby A, Sverdlov A, Qin F, Luptak I, Wang K, Sun X, Vijay A, Croteau D, Bachschmid M, Cohen RA, Walsh K, Colucci WS. Partial Liver Kinase B1 (LKB1) Deficiency Promotes Diastolic Dysfunction, De Novo Systolic Dysfunction, Apoptosis, and Mitochondrial Dysfunction With Dietary Metabolic Challenge Journal Of The American Heart Association 2015, 5: e002277. PMID: 26722122, PMCID: PMC4859355, DOI: 10.1161/jaha.115.002277.
• Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?Blankstein R, Miller EJ. Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it? Journal Of Nuclear Cardiology 2015, 23: 1467-1469. PMID: 26494648, DOI: 10.1007/s12350-015-0293-2.
• Multicenter Experience of Technetium Pyrophosphate Scanning for Diagnosing TTR Cardiac Amyloid: A Revival in Nuclear CardiologyCastano A, Grogan M, Johnson G, Dispenzieri A, Ruberg F, Berk J, Miller E, Maurer M, Bokhari S. Multicenter Experience of Technetium Pyrophosphate Scanning for Diagnosing TTR Cardiac Amyloid: A Revival in Nuclear Cardiology Journal Of Cardiac Failure 2015, 21: s85. DOI: 10.1016/j.cardfail.2015.06.258.
• AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolismSung MM, Zordoky BN, Bujak AL, Lally JS, Fung D, Young ME, Horman S, Miller EJ, Light PE, Kemp BE, Steinberg GR, Dyck JR. AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism Cardiovascular Research 2015, 107: 235-245. PMID: 26023060, PMCID: PMC4565988, DOI: 10.1093/cvr/cvv166.
• Multimodality Imaging of Cardiac SarcoidosisBlankstein R, Miller E. Multimodality Imaging of Cardiac Sarcoidosis 2015, 51-72. DOI: 10.1007/978-3-319-14624-9_7.
• Cases in Cardiac SarcoidosisFreeman A, Weinbeger H, Kim D, Fenster B, Schroeder J, Hamzeh N, Sauer W, Zipse M, Patel D, Blankstein R, Dorbala S, Miller E, Lakdawala N, Stewart G. Cases in Cardiac Sarcoidosis 2015, 135-159. DOI: 10.1007/978-3-319-14624-9_14.
• Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overloadElezaby A, Sverdlov AL, Tu VH, Soni K, Luptak I, Qin F, Liesa M, Shirihai OS, Rimer J, Schaffer JE, Colucci WS, Miller EJ. Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload Journal Of Molecular And Cellular Cardiology 2014, 79: 275-283. PMID: 25497302, PMCID: PMC4301992, DOI: 10.1016/j.yjmcc.2014.12.001.
• Abstract 12622: Western Diet for One Month Impairs Myocardial Energetics and Both Systolic and Diastolic Pump Function in the Mouse HeartLuptak I, Sverdlov A, Elezaby A, Miller E, Pimentel D, Liesa M, Shirihai O, Cohen R, Balschi J, Colucci W. Abstract 12622: Western Diet for One Month Impairs Myocardial Energetics and Both Systolic and Diastolic Pump Function in the Mouse Heart Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.12622.
• High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex IISverdlov AL, Elezaby A, Behring JB, Bachschmid MM, Luptak I, Tu VH, Siwik DA, Miller EJ, Liesa M, Shirihai OS, Pimentel DR, Cohen RA, Colucci WS. High fat, high sucrose diet causes cardiac mitochondrial dysfunction due in part to oxidative post-translational modification of mitochondrial complex II Journal Of Molecular And Cellular Cardiology 2014, 78: 165-173. PMID: 25109264, PMCID: PMC4268348, DOI: 10.1016/j.yjmcc.2014.07.018.
• A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic propertiesDahmani R, Just P, Delay A, Canal F, Finzi L, Prip-Buus C, Lambert M, Sujobert P, Buchet-Poyau K, Miller E, Cavard C, Marmier S, Terris B, Billaud M, Perret C. A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties Oncogene 2014, 34: 2337-2346. PMID: 24998845, DOI: 10.1038/onc.2014.182.
• Preclinical Left Ventricular Diastolic Dysfunction in Metabolic SyndromeAyalon N, Gopal DM, Mooney DM, Simonetti JS, Grossman JR, Dwivedi A, Donohue C, Perez AJ, Downing J, Gokce N, Miller EJ, Liang CS, Apovian CM, Colucci WS, Ho JE. Preclinical Left Ventricular Diastolic Dysfunction in Metabolic Syndrome The American Journal Of Cardiology 2014, 114: 838-842. PMID: 25084691, PMCID: PMC4162746, DOI: 10.1016/j.amjcard.2014.06.013.
• Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosisAhmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, Govender P, Ruberg FL, Miller EJ. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis Journal Of Nuclear Cardiology 2014, 21: 925-939. PMID: 24879453, DOI: 10.1007/s12350-014-9901-9.
• Scadding revisited: a proposed staging system for cardiac sarcoidosis.Berman JS, Govender P, Ruberg FL, Mazzini M, Miller EJ. Scadding revisited: a proposed staging system for cardiac sarcoidosis. Sarcoidosis, Vasculitis, And Diffuse Lung Diseases 2014, 31: 2-5. PMID: 24751447.
• Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heartLi J, Qi D, Cheng H, Hu X, Miller EJ, Wu X, Russell KS, Mikush N, Zhang J, Xiao L, Sherwin RS, Young LH. Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart Proceedings Of The National Academy Of Sciences Of The United States Of America 2013, 110: 16133-16138. PMID: 24043794, PMCID: PMC3791748, DOI: 10.1073/pnas.1312775110.
• Evaluation of Chest PainMiller E. Evaluation of Chest Pain 2013, 3-13. DOI: 10.1007/978-1-4471-4441-0_1.
• Nuclear Tracers for Transthyretin Cardiac AmyloidosisRuberg FL, Miller EJ. Nuclear Tracers for Transthyretin Cardiac Amyloidosis Circulation Cardiovascular Imaging 2013, 6: 162-164. PMID: 23512778, DOI: 10.1161/circimaging.113.000178.
• Cardiac-Specific Fatty Acid Transport Protein 1 (FATP1) Overexpression Causes Decreased Mitochondrial Respiration, Increased Oxidative Stress and Activation of AMPKElezaby A, Miller E, Qin F, Liesa M, Shirihai O, Colucci W. Cardiac-Specific Fatty Acid Transport Protein 1 (FATP1) Overexpression Causes Decreased Mitochondrial Respiration, Increased Oxidative Stress and Activation of AMPK Free Radical Biology And Medicine 2012, 53: s159. DOI: 10.1016/j.freeradbiomed.2012.10.434.
• MIF in Cardiovascular DiseaseMiller E, Qi D, Li J, Young L. MIF in Cardiovascular Disease 2012, 347-358. DOI: 10.1142/9789814335362_0018.
• Erratum to: Patient-centered imagingDePuey E, Mahmarian J, Miller T, Einstein A, Hansen C, Holly T, Miller E, Polk D, Samuel Wann L. Erratum to: Patient-centered imaging Journal Of Nuclear Cardiology 2012, 19: 633-633. DOI: 10.1007/s12350-012-9540-y.
• The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in MiceQin F, Siwik DA, Luptak I, Hou X, Wang L, Higuchi A, Weisbrod RM, Ouchi N, Tu VH, Calamaras TD, Miller EJ, Verbeuren TJ, Walsh K, Cohen RA, Colucci WS. The Polyphenols Resveratrol and S17834 Prevent the Structural and Functional Sequelae of Diet-Induced Metabolic Heart Disease in Mice Circulation 2012, 125: 1757-1764. PMID: 22388319, PMCID: PMC3354628, DOI: 10.1161/circulationaha.111.067801.
• Patient-centered imagingDePuey EG, Mahmarian JJ, Miller TD, Einstein AJ, Hansen CL, Holly TA, Miller EJ, Polk DM, Samuel Wann L. Patient-centered imaging Journal Of Nuclear Cardiology 2012, 19: 185-215. PMID: 22328324, DOI: 10.1007/s12350-012-9523-z.
• Highlights of the 2011 Scientific Session of the American Society of Nuclear CardiologyRussell RR, Abbott BG, Arrighi JA, Blankstein R, Faber TL, Mahmarian JJ, Miller EJ, Miller TD, Shaw LJ, Soman P, Travin MI. Highlights of the 2011 Scientific Session of the American Society of Nuclear Cardiology Journal Of Nuclear Cardiology 2011, 19: 158-164. PMID: 22071955, DOI: 10.1007/s12350-011-9479-4.
• A small molecule AMPK activator protects the heart against ischemia–reperfusion injuryKim AS, Miller EJ, Wright TM, Li J, Qi D, Atsina K, Zaha V, Sakamoto K, Young LH. A small molecule AMPK activator protects the heart against ischemia–reperfusion injury Journal Of Molecular And Cellular Cardiology 2011, 51: 24-32. PMID: 21402077, PMCID: PMC4005884, DOI: 10.1016/j.yjmcc.2011.03.003.
• Highlights of the 2010 Scientific Session of the American Society of Nuclear CardiologyRussell R, Abbott B, Arrighi J, Blankstein R, Cohen M, Faber T, Mahmarian J, Miller E, Shaw L, Soman P, Travin M. Highlights of the 2010 Scientific Session of the American Society of Nuclear Cardiology Journal Of Nuclear Cardiology 2010, 18: 177-184. DOI: 10.1007/s12350-010-9318-z.
• Practicing internal medicine onboard the USNS COMFORT in the aftermath of the Haitian earthquake.Amundson D, Dadekian G, Etienne M, Gleeson T, Hicks T, Killian D, Kratovil K, Lewis C, Monsour M, Pasiuk B, Rhodes D, Miller EJ. Practicing internal medicine onboard the USNS COMFORT in the aftermath of the Haitian earthquake. Annals Of Internal Medicine 2010, 152: 733-7. PMID: 20197507, DOI: 10.7326/0003-4819-152-11-201006010-00215.
• AMP‐activated protein kinase: a core signalling pathway in the heartKim AS, Miller EJ, Young LH. AMP‐activated protein kinase: a core signalling pathway in the heart Acta Physiologica 2009, 196: 37-53. PMID: 19239414, DOI: 10.1111/j.1748-1716.2009.01978.x.
• An unusual case of nonbacterial thrombotic (marantic) endocarditisOzcan C, Miller EJ, Russell KS, Dewar ML, Rosenfeld LE. An unusual case of nonbacterial thrombotic (marantic) endocarditis Journal Of Thoracic And Cardiovascular Surgery 2008, 137: 239-241. PMID: 19154931, DOI: 10.1016/j.jtcvs.2008.01.019.
• Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heartMiller EJ, Li J, Leng L, McDonald C, Atsumi T, Bucala R, Young LH. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart Nature 2008, 451: 578-582. PMID: 18235500, DOI: 10.1038/nature06504.
• Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heartMiller EJ, Li J, Sinusas KM, Holman GD, Young LH. Infusion of a biotinylated bis-glucose photolabel: a new method to quantify cell surface GLUT4 in the intact mouse heart AJP Endocrinology And Metabolism 2007, 292: e1922-e1928. PMID: 17341550, DOI: 10.1152/ajpendo.00170.2006.
• Activation of AMPK α- and γ-isoform complexes in the intact ischemic rat heartLi J, Coven DL, Miller EJ, Hu X, Young ME, Carling D, Sinusas AJ, Young LH. Activation of AMPK α- and γ-isoform complexes in the intact ischemic rat heart AJP Heart And Circulatory Physiology 2006, 291: h1927-h1934. PMID: 16648175, DOI: 10.1152/ajpheart.00251.2006.
• AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic HeartLi J, Miller EJ, Ninomiya-Tsuji J, Russell RR, Young LH. AMP-Activated Protein Kinase Activates p38 Mitogen-Activated Protein Kinase by Increasing Recruitment of p38 MAPK to TAB1 in the Ischemic Heart Circulation Research 2005, 97: 872-879. PMID: 16179588, DOI: 10.1161/01.res.0000187458.77026.10.
• AMPK – A pivotal rheostat in the control of cardiac metabolismMiller E, Russell R, Li J, Young L. AMPK – A pivotal rheostat in the control of cardiac metabolism Drug Discovery Today Disease Mechanisms 2005, 2: 93-100. DOI: 10.1016/j.ddmec.2005.05.008.
• Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic HeartBaron SJ, Li J, Russell RR, Neumann D, Miller EJ, Tuerk R, Wallimann T, Hurley RL, Witters LA, Young LH. Dual Mechanisms Regulating AMPK Kinase Action in the Ischemic Heart Circulation Research 2005, 96: 337-345. PMID: 15653571, DOI: 10.1161/01.res.0000155723.53868.d2.
• Doctors and torture.Miller EJ. Doctors and torture. New England Journal Of Medicine 2004, 351: 1571-4; author reply 1571-4. PMID: 15473022.
• Blankstein R, Miller EJ. Multimodality Imaging of Cardiac Sarcoidosis: How to choose which test at what time and what they all mean. Cardiac Sarcoidosis: Key Concepts in Pathogenesis, Disease Management, and Interesting Cases. (edited by) Andrew Freeman and Howard Weinberger. 2015Blankstein R, Miller EJ. Multimodality Imaging of Cardiac Sarcoidosis: How to choose which test at what time and what they all mean. Cardiac Sarcoidosis: Key Concepts in Pathogenesis, Disease Management, and Interesting Cases. (edited by) Andrew Freeman and Howard Weinberger. 2015